Differential effects of comorbidity on antihypertensive and glucose-regulating treatment in diabetes mellitus - a cohort study

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Voorham, Jaco ^a   Haaijer Ruskamp, Flora M ^a   Wolffenbuttel, Bruce H R ^a   de Zeeuw, Dick ^a   Stolk, Ronald P ^a   Denig, Petra ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; INSULIN; ORAL ANTIDIABETIC AGENT; ANTIDIABETIC AGENT;

AGED; ARTICLE; COHORT ANALYSIS; COMORBIDITY; DIABETIC HYPERTENSION; FEMALE; HEALTH CARE MANAGEMENT; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; DIABETES MELLITUS; HYPERTENSION; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL;

ANTIHYPERTENSIVE AGENTS; COHORT STUDIES; DIABETES MELLITUS; HYPERTENSION; HYPOGLYCEMIC AGENTS; PROPORTIONAL HAZARDS MODELS;

EID: 84861852756     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038707     Document Type: Article

References (32)

1. Voorham J, Haaijer-Ruskamp FM, van der Meer K, de Zeeuw D, Wolffenbuttel BH, (2010) Identifying targets to improve treatment in type 2 diabetes; the Groningen Initiative to aNalyse Type 2 diabetes Treatment (GIANTT) observational study. Pharmacoepidemiol Drug Saf 19: 1078 1086.
2. Voorham J, Haaijer-Ruskamp FM, Wolffenbuttel BH, Stolk RP, Denig P, (2010) Cardiometabolic treatment decisions in patients with type 2 diabetes: the role of repeated measurements and medication burden. Qual Saf Health Care 19: 411 415.
3. Conwell LJ, Boult C, (2008) The effects of complications and comorbidities on the quality of preventive diabetes care: a literature review. Popul Health Manag 11: 217 228.
4. Piette JD, Kerr EA, (2006) The impact of comorbid chronic conditions on diabetes care. Diabetes Care 29: 725 731.
5. Safford MM, Shewchuk R, Qu H, Williams JH, Estrada CA, (2007) Reasons for not intensifying medications: differentiating "clinical inertia" from appropriate care. J Gen Intern Med 22: 1648 1655.
6. Hicks PC, Westfall JM, Van Vorst RF, Bublitz Emsermann C, Dickinson LM, (2006) Action or inaction? Decision making in patients with diabetes and elevated blood pressure in primary care. Diabetes Care 29: 2580 2585.
7. Parnes BL, Main DS, Dickinson LM, Niebauer L, Holcomb S, (2004) Clinical decisions regarding hba1c results in primary care. Diabetes Care 27: 13.
8. Kerr EA, Zikmund-Fisher BJ, Klamerus ML, Subramanian U, Hogan MM, (2008) The role of clinical uncertainty in treatment decisions for diabetic patients with uncontrolled blood pressure. Ann Intern Med 148: 717 727.
9. Parchman ML, Romero RL, Pugh JA, (2006) Encounters by patients with type 2 diabetes-complex and demanding: an observational study. Ann Fam Med 4: 40 45.
10. Parchman ML, Pugh JA, Romero RL, Bowers KW, (2007) Competing demands or clinical inertia: the case of elevated glycosylated hemoglobin. Ann Fam Med 5: 196 201.
11. Boyd CM, Darer J, Boult C, Fried LP, Boult L, (2005) Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 294: 716 724.
12. Caughey GE, Roughead EE, Vitry AI, McDermott RA, Shakib S, (2010) Comorbidity in the elderly with diabetes: Identification of areas of potential treatment conflicts. Diabetes Res Clin Pract 87: 385 393.
13. Cayea D, Boyd C, Durso SC, (2007) Individualising therapy for older adults with diabetes mellitus. Drugs Aging 24: 851 863.
14. Halanych JH, Safford MM, Keys WC, Person SD, Shikany JM, (2007) Burden of comorbid medical conditions and quality of diabetes care. Diabetes Care 30: 2999 3004.
15. Vitry AI, Roughead EE, Preiss AK, Ryan P, Ramsay EN, (2010) Influence of comorbidities on therapeutic progression of diabetes treatment in Australian veterans: a cohort study. PLoS One 5: e14024.
16. Woodard LD, Urech T, Landrum CR, Wang D, Petersen LA, (2011) Impact of Comorbidity Type on Measures of Quality for Diabetes Care. Med Care 49: 605 610.
17. Bolen SD, Samuels TA, Yeh HC, Marinopoulos SS, McGuire M, (2008) Failure to intensify antihypertensive treatment by primary care providers: a cohort study in adults with diabetes mellitus and hypertension. J Gen Intern Med 23: 543 550.
18. Chaudhry SI, Berlowitz DR, Concato J, (2005) Do age and comorbidity affect intensity of pharmacological therapy for poorly controlled diabetes mellitus? J Am Geriatr Soc 53: 1214 1216.
19. Krein SL, Hofer TP, Holleman R, Piette JD, Klamerus ML, (2009) More than a pain in the neck: how discussing chronic pain affects hypertension medication intensification. J Gen Intern Med 24: 911 916.
20. Lagu T, Weiner MG, Hollenbeak CS, Eachus S, Roberts CS, (2008) The impact of concordant and discordant conditions on the quality of care for hyperlipidemia. J Gen Intern Med 23: 1208 1213.
21. Turner BJ, Hollenbeak CS, Weiner M, Ten Have T, Tang SS, (2008) Effect of unrelated comorbid conditions on hypertension management. Ann Intern Med 148: 578 586.
22. Wang PS, Avorn J, Brookhart MA, Mogun H, Schneeweiss S, (2005) Effects of noncardiovascular comorbidities on antihypertensive use in elderly hypertensives. Hypertension 46: 273 279.
23. Voorham J, Denig P, (2007) Computerized extraction of information on the quality of diabetes care from free text in electronic patient records of general practitioners. J Am Med Inform Assoc 14: 349 354.
24. Lamberts H, Wood M, eds. (1987) International Classification of Primary Care (ICPC). Oxford University Press (ed.).
25. Sidorenkov G, Haaijer-Ruskamp FM, de Zeeuw D, Denig P, (2011) A Longitudinal Study Examining Adherence to Guidelines in Diabetes Care According to Different Definitions of Adequacy and Timeliness. PLoS One 6: e24278.
26. Kerr EA, Heisler M, Krein SL, Kabeto M, Langa KM, (2007) Beyond comorbidity counts: how do comorbidity type and severity influence diabetes patients' treatment priorities and self-management? J Gen Intern Med 22: 1635 1640.
27. WHO Collaborating Centre for Drug Statistics Methodology (2009) Guidelines for ATC classification and DDD assignment, 2010. WHO.
28. Turchin A, Shubina M, Chodos AH, Einbinder JS, Pendergrass ML, (2008) Effect of board certification on antihypertensive treatment intensification in patients with diabetes mellitus. Circulation 117: 623 628.
29. Grant RW, Cagliero E, Murphy-Sheehy P, Singer DE, Nathan DM, (2002) Comparison of hyperglycemia, hypertension, and hypercholesterolemia management in patients with type 2 diabetes. Am J Med 112: 603 609.
30. Voorham J, Haaijer-Ruskamp FM, Stolk RP, Wolffenbuttel BH, Denig P, (2008) Influence of elevated cardiometabolic risk factor levels on treatment changes in type 2 diabetes. Diabetes Care 31: 501 503.
31. Rodondi N, Peng T, Karter AJ, Bauer DC, Vittinghoff E, (2006) Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus. Ann Intern Med 144: 475 484.
32. Selby JV, Uratsu CS, Fireman B, Schmittdiel JA, Peng T, (2009) Treatment intensification and risk factor control: toward more clinically relevant quality measures. Med Care 47: 395 402.